{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:43:07Z","timestamp":1790772187450,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T00:00:00Z","timestamp":1701907200000},"content-version":"vor","delay-in-days":371,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["1P01HL160472-01"],"award-info":[{"award-number":["1P01HL160472-01"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30DK 120515"],"award-info":[{"award-number":["P30DK 120515"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA198103"],"award-info":[{"award-number":["CA198103"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK113171"],"award-info":[{"award-number":["DK113171"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.ymthe.2022.10.004","type":"journal-article","created":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T07:19:37Z","timestamp":1665731977000},"page":"3542-3551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Ectopic clotting factor VIII expression and misfolding in hepatocytes as a cause for hepatocellular carcinoma"],"prefix":"10.1016","volume":"30","author":[{"given":"Audrey","family":"Kapelanski-Lamoureux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhouji","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zu-Hua","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruishu","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthoula","family":"Lazaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Lebeaupin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Giles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenhui","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ype P.","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Metrakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland W.","family":"Herzog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4277-316X","authenticated-orcid":false,"given":"Randal J.","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2022.10.004_bib1","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.hoc.2021.07.006","article-title":"Hemophilia A (factor VIII deficiency)","volume":"35","author":"Seaman","year":"2021","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.ymthe.2022.10.004_bib2","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1182\/asheducation-2016.1.657","article-title":"Hemophilia and inhibitors: current treatment options and potential new therapeutic approaches","volume":"2016","author":"Meeks","year":"2016","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"issue":"Suppl 2","key":"10.1016\/j.ymthe.2022.10.004_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1351-8216.2001.00115.x","article-title":"Manufacturing challenges in the commercial production of recombinant coagulation factor VIII","volume":"8","author":"Jiang","year":"2002","journal-title":"Haemophilia."},{"key":"10.1016\/j.ymthe.2022.10.004_bib4","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1111\/j.1538-7836.2005.01367.x","article-title":"The promise and challenges of bioengineered recombinant clotting factors","volume":"3","author":"Pipe","year":"2005","journal-title":"J.\u00a0Thromb. Haemost."},{"key":"10.1016\/j.ymthe.2022.10.004_bib5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1055\/s-0038-1646551","article-title":"Structure-function relationships of factor VIII elucidated through recombinant DNA technology","volume":"61","author":"Pittman","year":"1989","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ymthe.2022.10.004_bib6","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1182\/blood-2014-02-554501","article-title":"Murine coagulation factor VIII is synthesized in endothelial cells","volume":"123","author":"Everett","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2022.10.004_bib7","doi-asserted-by":"crossref","first-page":"5939","DOI":"10.1073\/pnas.83.16.5939","article-title":"A large region (approximately equal to 95\u00a0kDa) of human factor VIII is dispensable for in\u00a0vitro procoagulant activity","volume":"83","author":"Toole","year":"1986","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2022.10.004_bib8","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1182\/blood.V81.11.2925.2925","article-title":"Biochemical, immunological, and in\u00a0vivo functional characterization of B-domain-deleted factor VIII","volume":"81","author":"Pittman","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2022.10.004_bib9","doi-asserted-by":"crossref","first-page":"18525","DOI":"10.1073\/pnas.0809677105","article-title":"Antioxidants reduce endoplasmic reticulum stress and improve protein secretion","volume":"105","author":"Malhotra","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2022.10.004_bib10","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1046\/j.1365-2516.2003.00708.x","article-title":"The safety and efficacy of B-domain deleted recombinant factor VIII concentrate in patients with severe haemophilia A","volume":"9","author":"Lusher","year":"2003","journal-title":"Haemophilia."},{"key":"10.1016\/j.ymthe.2022.10.004_bib11","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1365-2516.2005.01099.x","article-title":"The safety and efficacy of B-domain deleted recombinant factor VIII concentrates in patients with severe haemophilia A: an update","volume":"11","author":"Lusher","year":"2005","journal-title":"Haemophilia"},{"key":"10.1016\/j.ymthe.2022.10.004_bib12","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1365-2516.2006.01420.x","article-title":"ReFacto and Advate: a single-dose, randomized, two-period crossover pharmacokinetics study in subjects with haemophilia A","volume":"13","author":"Di Paola","year":"2007","journal-title":"Haemophilia"},{"key":"10.1016\/j.ymthe.2022.10.004_bib13","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1182\/blood-2010-05-282707","article-title":"Codon optimization of human factor VIII cDNAs leads to high-level expression","volume":"117","author":"Ward","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2022.10.004_bib14","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMoa1708483","article-title":"AAV5-Factor VIII gene transfer in severe hemophilia A","volume":"377","author":"Rangarajan","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2022.10.004_bib15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJMoa1908490","article-title":"Multiyear follow-up of AAV5-hFVIII-SQ gene therapy for hemophilia A","volume":"382","author":"Pasi","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2022.10.004_bib16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2174\/1566523034578285","article-title":"F rom virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy","volume":"3","author":"Grimm","year":"2003","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.ymthe.2022.10.004_bib17","article-title":"Gene therapy for hemophilia: facts and quandaries in the 21st century","volume":"12","author":"Arruda","year":"2020","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"10.1016\/j.ymthe.2022.10.004_bib18","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1182\/blood-2003-10-3591","article-title":"Bioengineering of coagulation factor VIII for improved secretion","volume":"103","author":"Miao","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2022.10.004_bib19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0092-8674(00)81146-0","article-title":"Mutations in the ER-Golgi intermediate compartment protein ERGIC-53 cause combined deficiency of coagulation factors V and VIII","volume":"93","author":"Nichols","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2022.10.004_bib20","doi-asserted-by":"crossref","first-page":"8537","DOI":"10.1074\/jbc.273.14.8537","article-title":"Differential interaction of coagulation factor VIII and factor V with protein chaperones calnexin and calreticulin","volume":"273","author":"Pipe","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2022.10.004_bib21","doi-asserted-by":"crossref","first-page":"32539","DOI":"10.1074\/jbc.274.46.32539","article-title":"Mannose-dependent endoplasmic reticulum (ER)-Golgi intermediate compartment-53-mediated ER to Golgi trafficking of coagulation factors V and VIII","volume":"274","author":"Moussalli","year":"1999","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2022.10.004_bib22","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1046\/j.1538-7836.2003.00415.x","article-title":"LMAN1 is a molecular chaperone for the secretion of coagulation factor VIII","volume":"1","author":"Cunningham","year":"2003","journal-title":"J.\u00a0Thromb. Haemost."},{"key":"10.1016\/j.ymthe.2022.10.004_bib23","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/ng1153","article-title":"Bleeding due to disruption of a cargo-specific ER-to-Golgi transport complex","volume":"34","author":"Zhang","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2022.10.004_bib24","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1182\/blood-2005-09-3620","article-title":"Combined deficiency of factor V and factor VIII is due to mutations in either LMAN1 or MCFD2","volume":"107","author":"Zhang","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2022.10.004_bib25","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/hae.14391","article-title":"Persistence of haemostatic response following gene therapy with valoctocogene roxaparvovec in severe haemophilia A","volume":"27","author":"Pasi","year":"2021","journal-title":"Haemophilia"},{"key":"10.1016\/j.ymthe.2022.10.004_bib26","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/j.ymthe.2020.09.019","article-title":"Gene therapy for hemophilia: are expectations matching reality?","volume":"28","author":"Pierce","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2022.10.004_bib27","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/hae.14131","article-title":"Gene therapy to cure haemophilia: is robust scientific inquiry the missing factor?","volume":"26","author":"Pierce","year":"2020","journal-title":"Haemophilia"},{"key":"10.1016\/j.ymthe.2022.10.004_bib28","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/s41587-020-0693-y","article-title":"A reprieve from hemophilia A, but for how long?","volume":"38","author":"Sheridan","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2022.10.004_bib29","doi-asserted-by":"crossref","first-page":"e540","DOI":"10.1097\/HS9.0000000000000540","article-title":"Hemophilia gene therapy: approaching the\u00a0first\u00a0licensed product","volume":"5","author":"Batty","year":"2021","journal-title":"Hemasphere"},{"key":"10.1016\/j.ymthe.2022.10.004_bib30","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1146\/annurev-virology-101416-041936","article-title":"Overcoming the host immune response to adeno-associated virus gene delivery vectors: the race between clearance, tolerance, neutralization, and escape","volume":"4","author":"Mingozzi","year":"2017","journal-title":"Annu. Rev. Virol."},{"key":"10.1016\/j.ymthe.2022.10.004_bib31","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ccr.2014.07.001","article-title":"ER stress cooperates with hypernutrition to trigger TNF-dependent spontaneous HCC development","volume":"26","author":"Nakagawa","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ymthe.2022.10.004_bib32","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1182\/blood.2019002867","article-title":"Factor VIII exhibits chaperone-dependent and glucose-regulated reversible amyloid formation in the endoplasmic reticulum","volume":"135","author":"Poothong","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2022.10.004_bib33","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1016\/j.ymthe.2021.10.025","article-title":"Eliminating Panglossian thinking in development of AAV therapeutics","volume":"29","author":"Kaczmarek","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2022.10.004_bib34","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1016\/j.ymthe.2021.10.024","article-title":"Topics in AAV integration come front and center at ASGCT AAV Integration Roundtable","volume":"29","author":"Sabatino","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2022.10.004_bib35","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.ymthe.2020.10.018","article-title":"Liver injury increases the incidence of HCC following AAV gene therapy in mice","volume":"29","author":"Dalwadi","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2022.10.004_bib36","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/sj.gt.3300947","article-title":"Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA","volume":"6","author":"Liu","year":"1999","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2022.10.004_bib37","first-page":"1233","article-title":"Effect of von Willebrand factor coexpression on the synthesis and secretion of factor VIII in Chinese hamster ovary cells","volume":"9","author":"Kaufman","year":"1989","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ymthe.2022.10.004_bib38","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1074\/jbc.REV118.002804","article-title":"The endoplasmic reticulum (ER) chaperone BiP is a master regulator of ER functions: getting by with a little help from ERdj friends","volume":"294","author":"Pobre","year":"2019","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2022.10.004_bib39","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1091\/mbc.3.2.143","article-title":"Analysis in\u00a0vivo of GRP78-BiP\/substrate interactions and their role in induction of the GRP78-BiP gene","volume":"3","author":"Ng","year":"1992","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.ymthe.2022.10.004_bib40","article-title":"Epitope-tagging of the endogenous murine BiP\/GRP78\/Hspa5 locus allows direct analysis of the BiP interactome and protein misfolding in\u00a0vivo","author":"Peng","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.ymthe.2022.10.004_bib41","doi-asserted-by":"crossref","first-page":"e08961","DOI":"10.7554\/eLife.08961","article-title":"Physiological modulation of BiP activity by trans-protomer engagement of the interdomain linker","volume":"4","author":"Preissler","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.ymthe.2022.10.004_bib42","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1073\/pnas.1919035117","article-title":"Expansion, in\u00a0vivo-ex\u00a0vivo cycling, and genetic manipulation of primary human hepatocytes","volume":"117","author":"Michailidis","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2022.10.004_bib43","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1126\/science.1176639","article-title":"ER stress controls iron metabolism through induction of hepcidin","volume":"325","author":"Vecchi","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2022.10.004_bib44","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.bbrc.2009.07.047","article-title":"CRELD2 is a novel endoplasmic reticulum stress-inducible gene","volume":"387","author":"Oh-hashi","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymthe.2022.10.004_bib45","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41556-020-0539-3","article-title":"Publisher Correction: ROCK-mediated selective activation of PERK signalling causes fibroblast reprogramming and tumour progression through a CRELD2-dependent mechanism","volume":"22","author":"Boyle","year":"2020","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ymthe.2022.10.004_bib46","doi-asserted-by":"crossref","first-page":"152510","DOI":"10.1016\/j.prp.2019.152510","article-title":"Key genes associated with diabetes mellitus and hepatocellular carcinoma","volume":"215","author":"Liu","year":"2019","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.ymthe.2022.10.004_bib47","doi-asserted-by":"crossref","first-page":"e21939","DOI":"10.1096\/fj.202002713RR","article-title":"Creld2 function during unfolded protein response is essential for liver metabolism homeostasis","volume":"35","author":"Kern","year":"2021","journal-title":"FASEB J."},{"key":"10.1016\/j.ymthe.2022.10.004_bib48","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1440-1827.1996.tb03544.x","article-title":"Enhanced CD34 expression of sinusoid-like vascular endothelial cells in hepatocellular carcinoma","volume":"46","author":"Cui","year":"1996","journal-title":"Pathol. Int."},{"key":"10.1016\/j.ymthe.2022.10.004_bib49","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.7314\/APJCP.2015.16.11.4769","article-title":"Roles of combined glypican-3 and glutamine synthetase in differential diagnosis of hepatocellular lesions","volume":"16","author":"Wasfy","year":"2015","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.ymthe.2022.10.004_bib50","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/hep.21531","article-title":"Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis","volume":"45","author":"Di Tommaso","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.ymthe.2022.10.004_bib51","doi-asserted-by":"crossref","first-page":"100759","DOI":"10.1016\/j.blre.2020.100759","article-title":"Discussing investigational AAV gene therapy with hemophilia patients: a guide","volume":"47","author":"Sidonio","year":"2021","journal-title":"Blood Rev."},{"key":"10.1016\/j.ymthe.2022.10.004_bib52","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1126\/science.367.6474.131","article-title":"How safe is a popular gene therapy vector?","volume":"367","author":"Kaiser","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2022.10.004_bib53","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.devcel.2008.10.015","article-title":"UPR pathways combine to prevent hepatic steatosis caused by ER stress-mediated suppression of transcriptional master regulators","volume":"15","author":"Rutkowski","year":"2008","journal-title":"Dev. Cell"},{"key":"10.1016\/j.ymthe.2022.10.004_bib54","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.cell.2005.11.040","article-title":"Endoplasmic reticulum stress activates cleavage of CREBH to induce a systemic inflammatory response","volume":"124","author":"Zhang","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2022.10.004_bib55","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.ymthe.2021.03.009","article-title":"Liver gene therapy and hepatocellular carcinoma: a complex web","volume":"29","author":"de Jong","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2022.10.004_bib56","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cmet.2018.10.012","article-title":"Preclinical models for studying NASH-driven HCC: how useful are they?","volume":"29","author":"Febbraio","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.ymthe.2022.10.004_bib57","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.3390\/cancers13051095","article-title":"From liver fat to cancer: perils of the western diet","volume":"13","author":"Kim","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ymthe.2022.10.004_bib58","doi-asserted-by":"crossref","first-page":"16064","DOI":"10.1038\/mtm.2016.64","article-title":"Overexpression of factor VIII after AAV delivery is transiently associated with cellular stress in hemophilia A mice","volume":"3","author":"Lange","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2022.10.004_bib59","doi-asserted-by":"crossref","first-page":"16063","DOI":"10.1038\/mtm.2016.63","article-title":"Potential for cellular stress response to hepatic factor VIII expression from AAV vector","volume":"3","author":"Zolotukhin","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2022.10.004_bib60","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.omtm.2020.07.005","article-title":"Induction of ER stress by an AAV5 BDD FVIII construct is dependent on the strength of the hepatic-specific promoter","volume":"18","author":"Fong","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2022.10.004_bib61","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA. Cancer J. Clin."},{"key":"10.1016\/j.ymthe.2022.10.004_bib62","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1053\/j.gastro.2016.11.020","article-title":"Incidence of hepatocellular carcinoma in all 50\u00a0United States, from 2000 through 2012","volume":"152","author":"White","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ymthe.2022.10.004_bib63","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jceh.2018.02.006","article-title":"The changing face of hepatocellular carcinoma: forecasting prevalence of nonalcoholic steatohepatitis and hepatitis C cirrhosis","volume":"9","author":"Ahmed","year":"2019","journal-title":"J.\u00a0Clin. Exp. Hepatol."},{"key":"10.1016\/j.ymthe.2022.10.004_bib64","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2022.10.004_bib65","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nrc3800","article-title":"The impact of the endoplasmic reticulum protein-folding environment on cancer development","volume":"14","author":"Wang","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ymthe.2022.10.004_bib66","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/nature17041","article-title":"Protein misfolding in the endoplasmic reticulum as a conduit to human disease","volume":"529","author":"Wang","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2022.10.004_bib67","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jhep.2010.11.005","article-title":"Endoplasmic reticulum stress in liver disease","volume":"54","author":"Malhi","year":"2011","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.ymthe.2022.10.004_bib68","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jhep.2018.06.008","article-title":"Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease","volume":"69","author":"Lebeaupin","year":"2018","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.ymthe.2022.10.004_bib69","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/febs.14389","article-title":"Liver function and dysfunction - a unique window into the physiological reach of ER stress and the unfolded protein response","volume":"286","author":"Rutkowski","year":"2019","journal-title":"FEBS J."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001622006165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001622006165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:06:40Z","timestamp":1761502000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001622006165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":69,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S1525001622006165"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2022.10.004","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.01.19.427220","asserted-by":"object"}],"has-review":[{"id-type":"doi","id":"10.3410\/f.742366360.793596505","asserted-by":"object"}]},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ectopic clotting factor VIII expression and misfolding in hepatocytes as a cause for hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2022.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}